Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention

被引:6
|
作者
Hwang, In-Chang [1 ,2 ,3 ,4 ]
Kim, Chee Hae [5 ]
Kim, Jae-Young [6 ]
Choi, Hong-Mi [2 ,3 ,4 ]
Yoon, Yeonyee E. [2 ,3 ,4 ]
Cho, Goo-Yeong [2 ,3 ,4 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, 82 Gumi ro 173 Beon gil, Seongnam Si 13620, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Bundang Hosp, Seongnam, Gyeonggi, South Korea
[4] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Vet Hlth Serv Med Ctr, Seoul, South Korea
[6] Soonchunhyang Univ, Dept Stat, Bucheon Hosp, Bucheon, Gyeonggi, South Korea
关键词
cardiovascular diseases; cardiovascular risk factors; cardiovascular risk score; primary prevention; prognosis; ASSOCIATION; VALIDATION;
D O I
10.1161/HYPERTENSIONAHA.122.20678
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND:Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate ( increment 10-year ASCVD risk/year) are unknown. METHODS:A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data. The primary end point was a composite of myocardial infarction, stroke, coronary revascularization, and all-cause death. RESULTS:ASCVD event rates were proportional to the increment 10-year ASCVD risk/year regardless of the baseline 10-year ASCVD risk. Adjusted hazard ratio for ASCVD events per 1% increase in increment 10-year ASCVD risk/year was 1.53 (95% CI, 1.44-1.63), 1.24 (95% CI, 1.15-1.32), 1.18 (95% CI, 1.13-1.23), and 1.05 (95% CI, 1.00-1.10) in those with a baseline 10-year ASCVD risk of <5%, 5% to 7.5%, 7.5% to 20%, and & GE;20%, respectively. Appropriate control of risk factors, including low-density lipoprotein cholesterol, blood pressure, body mass index, exercise habits, and smoking status, was associated with lower ASCVD event rates, whereas failure to control these risk factors resulted in higher ASCVD event rates. CONCLUSIONS:The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The increment 10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.
引用
收藏
页码:1697 / 1706
页数:10
相关论文
共 50 条
  • [1] The influence of the baseline 10-year atherosclerotic cardiovascular disease risk on cardiovascular outcomes with aspirin for primary prevention: a meta-regression analysis
    Mahmoud, Ahmed N.
    Elgendye, Islam Y.
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (02) : 175 - 176
  • [2] ASSOCIATION BETWEEN HEART RATE VARIABILITY AND 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK SCORE
    Han, Kun Hee
    Park, Kyung Chae
    Kim, Moon Jong
    Kim, Young Sang
    Chun, Hyejin
    ATHEROSCLEROSIS, 2017, 263 : E190 - E191
  • [3] Premature Menopause and 10-Year Risk Prediction of Atherosclerotic Cardiovascular Disease
    Freaney, Priya M.
    Ning, Hongyan
    Carnethon, Mercedes
    Allen, Norrina B.
    Wilkins, John
    Lloyd-Jones, Donald M.
    Khan, Sadiya S.
    JAMA CARDIOLOGY, 2021, 6 (12) : 1463 - 1465
  • [4] Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population
    Park, Sangwoo
    Kim, Yong-Giun
    Ann, Soe Hee
    Cho, Young-Rak
    Kim, Shin-Jae
    Han, Seungbong
    Park, Gyung-Min
    EPIDEMIOLOGY AND HEALTH, 2023, 45 : 1 - 10
  • [5] A FEASIBILITY STUDY ON 10-YEAR CVD RISK ASSESSMENT AS A PRIMARY PREVENTION TOOL FOR CARDIOVASCULAR DISEASE
    Shi, R.
    Lan, Y.
    Yu, W.
    VALUE IN HEALTH, 2017, 20 (05) : A275 - A276
  • [6] Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
    Dehghanbanadaki, Hojat
    Dodangeh, Salimeh
    Roudsari, Peyvand Parhizkar
    Hosseinkhani, Shaghayegh
    Khashayar, Pouria
    Noorchenarboo, Mohammad
    Rezaei, Negar
    Dilmaghani-Marand, Arezou
    Yoosefi, Moein
    Arjmand, Babak
    Khalagi, Kazem
    Najjar, Niloufar
    Kakaei, Ardeshir
    Bandarian, Fatemeh
    Meybodi, Hamid Aghaei
    Larijani, Bagher
    Razi, Farideh
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [7] HEPATIC STEATOSIS IS ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENT RATE AMONG PEOPLE AT LOW 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
    Karady, Julia
    Mayrhofer, Thomas
    Foldyna, Borek
    Lu, Michael T.
    Mehyerson, Nandini
    Hoffmann, Udo
    Pagidipati, Neha
    Shah, Svati
    Douglas, Pamela S.
    Ferencik, Maros
    Corey, Kathleen E.
    HEPATOLOGY, 2023, 78 : S140 - S141
  • [8] Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
    Kohli-Lynch, Ciaran N.
    Lewsey, James
    Boyd, Kathleen A.
    French, Dustin D.
    Jordan, Neil
    Moran, Andrew E.
    Sattar, Naveed
    Preiss, David
    Briggs, Andrew H.
    CIRCULATION, 2022, 145 (17) : 1312 - 1323
  • [9] Effects of Diet on 10-Year Atherosclerotic Cardiovascular Disease Risk (from the DASH Trial)
    Jeong, Sun Young
    Wee, Christina C.
    Kovell, Lara C.
    Plante, Timothy B.
    Miller, Edgar R.
    Appel, Lawrence J.
    Mukamal, Kenneth J.
    Juraschek, Stephen P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 1 - 8
  • [10] Improvement of the 10-Year Atherosclerotic Cardiovascular Disease (ASCVD) Risk Following Bariatric Surgery
    Guillermo Ponce de León-Ballesteros
    Hugo Sánchez-Aguilar
    Carlos A. Aguilar-Salinas
    Miguel F. Herrera
    Obesity Surgery, 2020, 30 : 3997 - 4003